Invesco Preferred ETF vs Relay Therapeutics Inc. Common Stock — how do they compare? Invesco Preferred ETF trades at $10.04 (market cap $3.64B), while Relay Therapeutics Inc. Common Stock trades at $17.39 (market cap $3.94B). The key difference: Invesco Preferred ETF and Relay Therapeutics Inc. Common Stock are close in size by market cap, and Relay Therapeutics Inc. Common Stock is trading nearer its 52-week high, Invesco Preferred ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Invesco Preferred ETF for 94 Days and Relay Therapeutics Inc. Common Stock for 0 Days on average.
| PGX | RLAY | |
|---|---|---|
Market Cap | $3.64B | $3.94B |
Volume | 6,969,114 | 3,432,928 |
52-Week High | $11.61 | $20.75 |
52-Week Low | $9.97 | $6.03 |
Typical Hold Time | 94 Days | 0 Days |
Sector | — | Health |
Enterprise Value | — | $3.06B |
Signals from Pluang's Aura AI — not financial advice
PGX trades at $9.97, down 0.89% with a bearish technical signal from moving averages despite oversold RSI readings. The stock shows identical support and resistance at $10, indicating consolidation. Recent dividend payments of $0.06 were declared for July and September 2026, providing income appeal. Financial ratios including P/E, P/S, and ROE are unavailable in current data, limiting fundamental visibility.
The outlook remains cautious due to bearish technical momentum and lack of current financial metrics. Income investors may find dividend payments attractive, but absence of earnings data and weak price action suggest near-term pressure. Key risks include undefined profitability and competitive challenges in the preferred ETF space highlighted by recent media coverage.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
The fund generally will invest at least 80% of its total assets in the components of the index. Strictly in accordance with its guidelines and mandated procedures, ICE Data Indices, LLC selects securities for the index, which is a market capitalization-weighted index designed to measure the performance of the fixed rate US dollar-denominated preferred securities market.
Read more on PGX →Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.
Read more on RLAY →